HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Request for Information: Drive Anticoagulation in Extracorporeal Membrane Oxygenation Therapy. The project location is USA and the tender is closing on 04 May 2021. The tender notice number is RFI-21-BARDA-0001, while the TOT Ref Number is 51612663. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Request for Information: Drive Anticoagulation in Extracorporeal Membrane Oxygenation Therapy

Deadline : 04 May 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 51612663

Document Ref. No. : RFI-21-BARDA-0001

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Request for Information: DRIVe Anticoagulation in Extracorporeal Membrane Oxygenation Therapy

Active Contract Opportunity

Notice ID : RFI-21-BARDA-0001

Related Notice

Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Office : ASPR BARDA DIV CONTRACTS MGMT & ACQ

General Information

Contract Opportunity Type: Sources Sought (Original)

All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Mar 23, 2021 05:04 pm EDT

Original Response Date: May 04, 2021 11:00 am EDT

Inactive Policy: 15 days after response date

Original Inactive Date: May 19, 2021

Initiative: None


Classification

Original Set Aside:

Product Service Code: AN13 - Health R&D Services; Health care services; Experimental Development

NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance:

Description

BARDA DRIVe is seeking information on developments in anticoagulation drugs, assays, and management in the specific context of extracorporeal membrane oxygenation (ECMO) therapy. The intent is to identify areas of innovation that can solve the challenges posed by anticoagulation in ECMO or improve on the ways this issue is currently being addressed. BARDA will not execute any awards based on this notice. Th...

Documents

 Tender Notice